Phebra Pty Ltd
Privately held: no public share price · Australia
Assets
(1 total)
1Total Assets
1Approved
0Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Approved | Glutathione precursor (cysteine donor)Small molecule | Toxicology / Acetaminophen Overdose Acetaminophen Overdose |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Regulatory and conference events
(1)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent
US, FDA · Source ↗
Financial reports
No financial reports recorded.